Nuevocor is a new biotech start-up in Singapore striving to develop gene therapies for genetic cardiomyopathies. It will leverage a deep understanding of cardiac cell biology, as well as a technology platform encompassing novel gene therapy vectors and proteomics-based target discovery
Employees: 11-50
Total raised: $24M
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | EVX Ventur... | evx.ventur... |
| - | SEEDS Capi... | seedscapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.06.2021 | Series A | $24M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 11.04.2024 | Nuevocor Strengthens Leadership Team with Appointment of Joh... | SINGAPORE and PHILADELPHIA, April 11, 2024 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnol... | en.prnasia... |
| 21.12.2022 | Nuevocor to Present at Biotech Showcase during JPM week and ... | SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- Nuevocor, a pre-clinical stage cardiac gene therapy company... | en.prnasia... |
| 03.11.2022 | SG gene therapy startup Nuevocor raises $11.6m additional fu... | Nuevocor, a Singapore-headquartered preclinical-stage biotech startup, has raised an additional $11.... | dealstreet... |
| 22.06.2021 | Nuevocor Closes US$24M Series A Financing | Nuevocor, a Singapore-based preclinical-stage biotech company specializing in gene therapy for cardi... | finsmes.co... |
| 18.06.2021 | Nuevocor closes US$24M Series A Financing to Advance Novel G... | SINGAPORE, June 18, 2021 /PRNewswire/ -- Nuevocor, a preclinical-stage biotech company specializing ... | en.prnasia... |
| 18.06.2021 | Nuevocor Closes US$24M Series A Financing | Nuevocor, a Singapore-based preclinical-stage biotech company specializing in gene therapy for cardi... | finsmes.co... |
| 18.06.2021 | SG biotech firm Nuevocor raises $24m in oversubscribed Serie... | Premium Nuevocor, a Singapore-headquartered preclinical-stage biotech startup, has announced raising... | dealstreet... |
| 18.06.2021 | SG biotech firm Nuevocor raises $24m in oversubscribed Serie... | Nuevocor, a Singapore-headquartered preclinical-stage biotech startup, has announced raising $24 mil... | dealstreet... |
| - | Nuevocor | “Nuevocor: Pioneering Novel Gene Therapies for Cardiomyopathies ” | fastfounde... |